Nosenzo John's Form 4 filing
Bioventus Inc. (BVS) · filed Apr 5, 2022
- Accession no.
- 0000899243-22-013963
- Filed
- Apr 5, 2022
- Trade date
- Apr 1-4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $733.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nosenzo JohnCIK 0001835973 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Class A Common Stock | MOption exerciseAcquired | +106,485 | – | – | 149,895 | Direct | |
| Apr 4, 2022 | Class A Common Stock | SSaleDisposed | −65,963 | $11.12 | −$733,508.56 | 83,932 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Class A Common Stock | MOption exerciseDisposed | −106,485 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.